Cyanotech (NASDAQ:CYAN) and Entia Biosciences (OTCMKTS:ERGO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.
Institutional & Insider Ownership
16.7% of Cyanotech shares are owned by institutional investors. 24.5% of Cyanotech shares are owned by insiders. Comparatively, 28.3% of Entia Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
This table compares Cyanotech and Entia Biosciences’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent recommendations and price targets for Cyanotech and Entia Biosciences, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Volatility & Risk
Cyanotech has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, Entia Biosciences has a beta of 4.94, meaning that its share price is 394% more volatile than the S&P 500.
Valuation and Earnings
This table compares Cyanotech and Entia Biosciences’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Cyanotech||$34.12 million||0.61||$1.02 million||N/A||N/A|
|Entia Biosciences||$260,000.00||1.31||-$1.39 million||N/A||N/A|
Cyanotech has higher revenue and earnings than Entia Biosciences.
Entia Biosciences beats Cyanotech on 6 of the 9 factors compared between the two stocks.
Cyanotech Company Profile
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.
Entia Biosciences Company Profile
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.